HELX Among Health Care ETFs
End-of-day Nov 12, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.8% | +2.2% | +2.4% | +6.1% | +18.3% | +21.9% | +59.9% | −17.6% | +80.7% |
| Peer average | −1.7% | +1.7% | +5.8% | +4.3% | +21.7% | +26.7% | +69.8% | +26.0% | — |
| S&P 500 · VOO | −0.3% | +3.3% | −1.6% | −2.2% | +11.9% | +12.1% | +80.1% | +73.9% | — |
$86 of every $1,000 in HELX is Guardant
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GHGuardant Health | Healthcare | 8.56% | $856.38 | 19K | $3.0M |
| 2 | NTRANatera | Healthcare | 8.03% | $802.67 | 8,775 | $2.8M |
| 3 | ADPTAdaptive Biotechnologies | Healthcare | 5.08% | $508.46 | 59K | $1.8M |
| 4 | KRYSKrystal Biotech | Healthcare | 4.80% | $480.03 | 5,435 | $1.7M |
| 5 | LGNDLigand Pharmaceuticals | Healthcare | 4.61% | $460.79 | 5,085 | $1.6M |
| 6 | BBIOBridgebio Pharma | Healthcare | 3.41% | $341.31 | 15K | $1.2M |
| 7 | TWSTTwist Bioscience | Healthcare | 3.39% | $339.15 | 9,673 | $1.2M |
| 8 | MEDPMedpace | Healthcare | 2.87% | $286.91 | 1,509 | $1.0M |
| 9 | LLYELI Lilly | Healthcare | 2.82% | $281.59 | 685 | $985K |
| 10 | UTHRUnited Therapeutics | Healthcare | 2.78% | $278.38 | 1,634 | $973K |
| 11 | VRTXVertex Pharmaceuticals IN | Healthcare | 2.76% | $276.15 | 1,765 | $966K |
| 12 | REGNRegeneron Pharmaceuticals | Healthcare | 2.52% | $252.17 | 919 | $882K |
| 13 | TVTXTravere Therapeutics | Healthcare | 2.41% | $240.57 | 16K | $841K |
| 14 | VYLRVylor | Basic Materials | 2.16% | $215.55 | 10K | $754K |
| 15 | TEMTempus AI | Healthcare | 2.13% | $212.59 | 9,358 | $743K |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GH | Guardant Health | 8.56% |
| 2 | NTRA | Natera | 8.03% |
| 3 | ADPT | Adaptive Biotechnologies | 5.08% |
| 4 | KRYS | Krystal Biotech | 4.80% |
| 5 | LGND | Ligand Pharmaceuticals | 4.61% |
| 6 | BBIO | Bridgebio Pharma | 3.41% |
| 7 | TWST | Twist Bioscience | 3.39% |
| 8 | MEDP | Medpace | 2.87% |
| 9 | LLY | ELI Lilly & | 2.82% |
| 10 | UTHR | United Therapeutics | 2.78% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 30, 2025 | Jan 8, 2026 | $0.14 |
| Dec 30, 2021 | Jan 7, 2022 | $0.0040 |
| Dec 13, 2021 | Dec 21, 2021 | $0.11 |
| Dec 14, 2020 | Dec 23, 2020 | $0.0520 |